Globus Medical (GMED)

Debt-to-equity ratio

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Long-term debt	US$ in thousands	417,400	409,723	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Total stockholders’ equity	US$ in thousands	3,997,960	4,187,280	1,985,060	1,914,820	1,846,370	1,764,110	1,699,090	1,785,370	1,741,390	1,718,270	1,639,270	1,562,990	1,506,300	1,417,200	1,336,920	1,363,370	1,402,450	1,338,800	1,287,530	1,237,210
Debt-to-equity ratio		0.10	0.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

December 31, 2023 calculation

Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $417,400K ÷ $3,997,960K
= 0.10

The debt-to-equity ratio of Globus Medical Inc has remained consistent at 0.10 in Q4 2023 and Q3 2023, indicating that the company has a moderate level of debt relative to its equity. However, it is worth noting that in the previous quarters (Q2 2023, Q1 2023, Q4 2022, Q3 2022, Q2 2022, Q1 2022), the debt-to-equity ratio was 0.00, implying that the company had no debt during those periods.

The stable debt-to-equity ratio of 0.10 in the recent quarters suggests that Globus Medical Inc has been managing its debt levels effectively while leveraging some debt to fund its operations or growth initiatives. This conservative approach to debt financing is generally viewed positively by investors as it signifies a lower level of financial risk and greater financial stability.

Overall, the consistent debt-to-equity ratio of 0.10 indicates that Globus Medical Inc maintains a healthy balance between debt and equity in its capital structure, which could potentially support the company's growth and long-term financial performance.